Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2001, p. 1305-1308, Vol. 45, No. 4
Área de Microbiología,
Departamento de Biología Funcional, Universidad de Oviedo,
33006 Oviedo, Principado de Asturias, Spain
Received 7 August 2000/Returned for modification 24 October
2000/Accepted 10 January 2001
A multidrug-resistant Salmonella enterica serotype
[4,5,12:i: Multidrug-resistant Salmonella
enterica serotype [4,5,12:i:
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.4.1305-1308.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Multidrug Resistance Is Mediated by Large Plasmids
Carrying a Class 1 Integron in the Emergent Salmonella
enterica Serotype [4,5,12:i:
]
![]()
ABSTRACT
Top
Abstract
Text
References
] clone carried a class 1 integron harboring
dfrA12 and aadA2 gene cassettes and
blaTEM-1, aac(3)-IV,
cmlA1, and tetA genes located in large plasmids
of about 140 kb (carrying spv) or 120 kb (lacking
spv). Several segregants, lacking multidrug resistance, contained a plasmid smaller than the parental one and no longer hybridized with probes for the lost resistances. The genes mediating resistance to ampicillin, chloramphenicol, and tetracycline in the
[4,5,12:i:
] clone are different from those found in the
pentadrug-resistant serotype Typhimurium DT104 clone.
![]()
TEXT
Top
Abstract
Text
References
] isolates emerged in 1997 in
Spain (5). DNA fingerprinting analysis of 29 isolates (27 collected in the Principality of Asturias between May 1997 and April
2000 and the reference strains CNM4IC and CNM9IC) had shown that they
fall into a single genetic lineage or clone which seems to be closely
related to some contemporary serotype Typhimurium lineages causing
human salmonellosis (reference 10 and unpublished data).
All [4,5,12:i:
] isolates expressed resistance to ampicillin (AMP),
chloramphenicol (CHL), gentamicin (GEN), streptomycin (STR),
sulfadiazine (SUL), tetracycline (TET), and trimethoprim (TMP) except
two isolates which were TET susceptible. These isolates harbored two or
three small cryptic plasmids and one large plasmid carrying (pUO-SVR3
[plasmid of University of Oviedo-Salmonella virulence
resistance]) or lacking (pUO-SR4) spv loci
(10) (Table 1). The
objective of this study was to investigate the molecular basis of the
multidrug resistance in serotype [4,5,12:i:
] and ascertain the
relations between resistance genes, integrons, and plasmids. For this,
several experimental approaches were made, and the results were
compared with those obtained for Typhimurium DT104 LSP14/92
(9), used as the type strain of a pentadrug-resistance
epidemic clone of concern in many countries (3, 7, 8, 9, 11,
15).
TABLE 1.
Features of multidrug-resistant Salmonella
serotype [4,5,12:i:
] isolates used in curing experiments and their
segregants
Determination of resistance genes.
To determine the genes for
AMP, GEN, and STR resistance, the [4,5,12:i:
] isolates were tested,
by disk diffusion assay (13) and taking into account
results described elsewhere (2, 16, 17), with (i)
amoxicillin-clavulanic acid (AMC; 30 µg), carbenicillin (CAR; 100 µg), cephalothin (30 µg), ceftazidime (30 µg), cefotaxime (30 µg), imipenem (10 µg), oxacillin (OXA; 1 µg), and piperacillin (PIP; 100 µg) and (ii) amikacin (30 µg), apramycin (APR; 100 µg), 5-episisomycin (5EPI; 10 µg), fortimycin (100 µg), kanamycin (30 µg), netilmicin (NET) and its derivatives 2'-NET- and 6'-NET (100 µg), tobramycin (TOB; 10 µg), and spectinomycin (SPT; 10 µg). PCR
amplication was performed using specific primers (Table
2). All [4,5,12:i:
] isolates showed
resistance to AMP-CAR-OXA, GEN-APR-5EPI-NET-2'NET-6'NET-TOB, and
STR-SPT and generated amplification products with the
blaTEM, aac(3)-IV, and
aadA primers. Typhimurium LSP14/92 showed resistance to
AMP-CAR-PIP-OXA-AMC and STR-SPT and generated the expected amplification products with the blaCARB and
aadA primers. PCR for other resistance genes using
[4,5,12:i:
] isolates generated amplification products with the
cmlA, dfrA12, tetA, and sul1 primers, while
Typhimurium LSP14/92 generated products with the floR, tetG, and sul1 primers. Sequencing of the 460-bp
blaTEM and 435-bp cmlA amplicons
generated by LSP389/97, conducted described elsewhere (9),
confirmed the presence of blaTEM-1-like and
cmlA1 genes (accession numbers AF126482.1 and U12338,
respectively). These data support the finding that the genes implicated
in AMP, CHL, and TET resistance in the [4,5,12:i:
] clone differ
from those reported for the pentadrug-resistant Typhimurium DT104
clone.
|
Detection of integrons.
Detection of class 1 integrons and the
resistance genes located therein was performed by PCR amplification
with specific primers (Table 2). All [4,5,12:i:
] isolates carried
two integrons defined by PCR products of 1,900 and 150 bp, sizes
indicating that only in the first could gene cassettes carrying
resistance genes be inserted. Class 1 integrons in their conserved
regions, in addition to the integrase (intI1) gene, usually
contain genes encoding resistance to quaternary ammonium compounds and
ethidium bromide (qacE
) and sulfonamides
(sul1) (6, 12, 14). The presence of these genes
was confirmed in all [4,5,12:i:
] isolates by PCR. Sequencing of the
1,900-bp amplicon from LSP389/97 confirmed the presence of the
dfrA12 (dhfrXII) gene cassette near the 5' conserved region
(5'CS), an open reading frame with an unknown function and a 59-bp
element, and the aadA2 gene cassette near the 3'CS (accession number AF284063). Intragenic primers for dfrA12 were used to confirm that this gene, together with aadA2,
was carried in the 1,900-bp amplicons from all [4,5,12:i:
] isolates studied. Typhimurium LSP14/92 carried two other integrons, with variable regions previously defined as 1,200-bp pse1 and
1,000-bp aadA2 (9).
Determination of relationships between drug resistance and
plasmids.
In a previous work, we found that when two
representative [4,5,12:i:
] isolates were grown in the presence of
sodium dodecyl sulfate (1%), some cells (segregants) lost AMP, CHL,
GEN, and TMP resistance and their large plasmids appeared to be smaller (10). To confirm the apparent relationship between drug
resistance and plasmids, as well as the possible relationship between
integrons and plasmids, we used the following approaches.
(i) New curing experiments using representative isolates of the four plasmid profiles. For each experiment we analyzed about 100 colonies, finding that some colonies had lost some resistances and could be grouped in segregant types. A strong correlation between phenotype and genotype was found in all segregants, and one colony of each type was selected for the following experiments (Table 1).
(ii) Integron analysis.
Using qacE
1, sul1, and
5'CS/3'CS primers, all segregant types generated amplification products
of about 250, 430, and 150 bp, respectively, but only some of them
generated products of 1,900 bp with dfrA12 primers and
expressed TMP resistance. Only some of the TMP-susceptible segregants
were also STR susceptible indicating that more than one gene was
implicated in STR resistance.
(iii) Plasmid analysis. None of the small cryptic plasmids was eliminated by curing, and all pUO-SVR3 segregants yielded an amplification product with spv primers. In segregants lacking the 1,900-bp dfrA12-aadA2 integron and the other resistance genes, pUO-SVR3 or pUO-SR4 derivatives were smaller than the original plasmids.
(iv) Plasmid DNA hybridization.
Hybridization using DNA from
parents and representative segregants was performed with probes for the
presumably lost genes and spvC. The results (Fig.
1) confirmed that 150- and 1,900-bp dfrA12-aadA2 integrons, as well as
blaTEM-1-like, aac(3)-IV, cmlA1, tetA, and spvC genes, were plasmid located.
|
] organisms remain to be determined.
| |
ACKNOWLEDGMENTS |
|---|
We thank M. A. González-Hevia (Laboratotio de Salud
Pública, LSP, Principado de Asturias, Spain) and M. A. Usera
and A. Echeitia (Centro Nacional de Microbiología, CNM, Madrid,
Spain) for Salmonella [4,5,12:i:
] isolates; we thank J. Ruiz and J. Vila for the design of cmlA primers and advice
regarding chloramphenicol resistance analysis.
This work was supported by a grant from the Fondo de Investigación Sanitaria (FIS 00/1084), Ministerio de Sanidad y Consumo, Spain. S. Soto is the recipient of a grant of Formación de Personal Investigador (Ref AP98), Ministerio de Educación y Cultura, Spain.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Área de Microbiología. Departamento de Biología Funcional, Facultad de Medicina, Universidad de Oviedo, Calle Julián Clavería 6, 33006 Oviedo, Spain. Phone: 34-985-103560. Fax: 34-985-103148. E-mail: camf{at}sauron.quimica.uniovi.es.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Arlet, G., and A. Phillippon.
1991.
Construction by polymerase chain reaction and intragenic DNA probes for three main types of transferable -lactamases (TEM, SHV, CARB).
FEMS Microbiol. Lett.
82:19-26[CrossRef].
|
| 2. |
Bush, K.,
G. A. Jacoby, and A. A. Medeiros.
1995.
A functional classification scheme for -lactamases and its correlation with molecular structure.
Antimicrob. Agents Chemother.
39:1211-1233[Medline].
|
| 3. |
Briggs, C. E., and P. Fratamico.
1999.
Molecular characterization of an antibiotic resistance gene cluster of Salmonella typhimurium DT104.
Antimicrob. Agents Chemother.
43:846-849 |
| 4. |
Davies, J.
1994.
Inactivation of antibiotics and the dissemination of resistance genes.
Science
264:375-382 |
| 5. |
Echeitia, M. A.,
A. Aladueña,
S. Cruchaga, and M. A. Usera.
1999.
Emergence and spread of an atypical Salmonella enterica subsp: enterica serotype 4,5,12:i: strain in Spain.
J. Clin. Microbiol.
37:3425 |
| 6. | Fluit, A. C., and F. J. Schmitz. 1999. Class 1 integrons, gene cassettes, mobility, and epidemiology. Eur. J. Clin. Microbiol. Infect. Dis. 18:761-770[CrossRef][Medline]. |
| 7. |
Gallardo, F.,
J. Ruiz,
F. Marco,
K. J. Towner, and J. Vila.
1999.
Increase of incidence of resistance to ampicillin, chloramphenicol and trimethoprim in clinical isolates of Salmonella serotype Typhimurium with investigation of molecular epidemiology and mechanisms of resistance.
J. Med. Microbiol.
48:367-374 |
| 8. |
Glynn, M. K.,
C. Boop,
W. Dewitt,
P. Dabney,
M. Moktar, and F. Angulo.
1998.
Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 infections in the United States.
N. Engl. J. Med.
338:1333-1338 |
| 9. |
Guerra, B.,
S. M. Soto,
S. Cal, and M. C. Mendoza.
2000.
Antimicrobial resistance and spread of class 1 integrons among Salmonella serotypes.
Antimicrob. Agents Chemother.
44:2166-2169 |
| 10. |
Guerra, B.,
I. Laconcha,
S. M. Soto,
M. A. González-Hevia, and M. C. Mendoza.
2000.
Molecular characterization of emergent multiresistant Salmonella enterica serotype [4,5,12:i: ] organisms causing human salmonellosis.
FEMS Microbiol. Lett.
190:341-347[Medline].
|
| 11. |
Lai-King, N. G.,
M. R. Mulvey,
I. Martin,
G. A. Petters, and W. Johnson.
1999.
Genetic characterization of antimicrobial resistance in Canadian isolates of Salmonella serovar Typhimurium DT104.
Antimicrob. Agents Chemother.
43:3018-3021 |
| 12. | Levèsque, C., L. Pyche, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:85-191. |
| 13. | National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standards and M2-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa. |
| 14. |
Recchia, G. D., and R. M. Hall.
1995.
Gene cassettes: a new class of mobile element.
Microbiology
141:3015-3027 |
| 15. | Sandvang, D., F. M. Aarestrup, and L. B. Jensen. 1997. Characterization of integrons and antibiotic resistance genes in Danish multiresistant Salmonella typhimurium DT104. FEMS Microbiol. Lett. 160:37-41[CrossRef]. |
| 16. | Shaw, K. J., F. J. Sabatelli, L. Naples, P. Mann, R. S. Hare, and G. Miller. 1998. The application of molecular techniques for the study of aminoglycoside resistance. Methods Mol. Med. 15:555-577. |
| 17. |
Terán, F. J.,
J. E. Suárez, and M. C. Mendoza.
1991.
Cloning, sequencing, and use as a molecular probe of a gene encoding an aminoglycoside 6'-N-acetyltransferase of broad substrate profile.
Antimicrob. Agents Chemother.
35:714-719 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»